Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
+905K
-
Total reported value, excl. options
-
$1.39B
-
Value change
-
+$29.8M
-
Put/Call ratio
-
1.57
-
Number of buys
-
106
-
Number of sells
-
-81
-
Price
-
$38.32
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2017
231 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2017.
REPLIGEN CORP - COMMON STOCK (RGEN) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
of 56.2M outstanding shares and own 64.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.28M shares), VANGUARD GROUP INC (2.84M shares), TimesSquare Capital Management, LLC (2.31M shares), OppenheimerFunds, Inc. (1.74M shares), Invesco Ltd. (1.68M shares), FMR LLC (1.46M shares), Conestoga Capital Advisors, LLC (1.45M shares), STATE STREET CORP (1.35M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.06M shares), and Stephens Investment Management Group LLC (919K shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.